Take the Dry Eye Quiz

Should You Get Screened for Chronic Dry Eye Disease?

Take this quiz to help determine if you may have a type of Chronic Dry Eye disease. After taking the quiz, share your results with an eye doctor and ask to get screened.


  1. I use artificial tears often (also known as over-the-counter lubricant eye drops).
    True False

    Approximately how often?
    Less than daily
    1 to 2 times per day
    3 or more times per day


  2. I usually carry artificial tears with me wherever I go.
    True False

  3. I have been using artificial tears for a long time.
    True False

    Approximately how long?
    Less than 1 year
    1 to 2 years
    More than 2 years


  4. I have tried multiple types of over-the-counter artificial tears.
    True False

    What types? (Check all that apply.)
    Lubricant eye drops (over-the-counter artificial tears)
    Lubricant eye gel (artificial tear in the form of a gel)
    Lubricant eye ointment (artificial tear in the form of an ointment)
    Contact lens rewetting eye drops

  5. My dry eyes are getting worse.
    True False

  6. Dry eyes affect my daily activities.
    True False

    Approximately how often?
    Less than daily
    Parts of the day
    All day



 

Approved Use

RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose®.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169_v6 08/18   © 2018 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.

Approved Use

RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion help increase your eyes’ natural ability to produce tears, which may be reduced by inflammation due to Chronic Dry Eye. RESTASIS® and RESTASIS MultiDose® did not increase tear production in patients using anti-inflammatory eye drops or tear duct plugs.

Important Safety Information

Do not use RESTASIS® and RESTASIS MultiDose® Ophthalmic Emulsion if you are allergic to any of the ingredients. Be careful not to touch the container tip to your eye or other surfaces, to help avoid eye injury and contamination. RESTASIS® and RESTASIS MultiDose® should not be used while wearing contact lenses. If contact lenses are worn, they should be removed prior to use of RESTASIS® and RESTASIS MultiDose® and may be reinserted after 15 minutes.

The most common side effect is a temporary burning sensation. Other side effects include eye redness, discharge, watery eyes, eye pain, foreign body sensation, itching, stinging, and blurred vision.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for full Product Information for RESTASIS® and RESTASIS MultiDose®.

View Desktop

Privacy Statement  |  Terms of Use  |  Contact Us  |
RES110169_v6 08/18   © 2018 Allergan, Inc. All rights reserved. This information is intended for residents of the United States. All trademarks are the property of their respective owners.